IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i18p6810-d415499.html
   My bibliography  Save this article

Hyperhomocysteinemia Concurrent with Metabolic Syndrome Is Independently Associated with Chronic Kidney Disease among Community-Dwelling Adults in an Urban Korean Population

Author

Listed:
  • Hana Moon

    (Department of Family Medicine, School of Medicine, Daegu Catholic University, Daegu 42472, Korea)

  • Hae-Jin Ko

    (Department of Family Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea
    Department of Family Medicine, Kyungpook National University Hospital, Daegu 41944, Korea)

  • A-Sol Kim

    (Department of Family Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea
    Department of Family Medicine, Kyungpook National University Chilgok Hospital, Daegu 41404, Korea)

Abstract

Elevated homocysteine (Hcy) levels and metabolic syndrome (MetS) are associated with chronic kidney disease (CKD). We investigated the combined effects of hyperhomocysteinemia (HHcy) and MetS on CKD among community-dwelling adults in an urban area of South Korea. We also identified the combination of HHcy and individual MetS components associated with the maximal risk of CKD. A retrospective cross-sectional study involving 19,311 health examinees between 2 January 2011 and 31 December 2015 was conducted. The participants were divided into four groups—namely, the HHcy−/MetS−, HHcy−/MetS+, HHcy+/MetS−, and HHcy+/MetS+ groups. CKD was defined as a low eGFR <60 mL/min/1.73 m 2 or albuminuria. The HHcy+/MetS+ group had a higher risk of CKD than the HHcy−/MetS+ group (odds ratio (OR): 1.750, p = 0.002 for males; OR: 3.224, p < 0.001 for females). The HHcy+/MetS+ group had a higher CKD risk than the HHcy+/MetS− group; however, the difference was not statistically significant (OR: 1.070, p = 0.712 for males; OR: 1.847, and p < 0.074 for females). HHcy concurrent with MetS increased the CKD risk. Among the combinations of HHcy and MetS components, the coexistence of HHcy and central obesity had the greatest effect on CKD. Therefore, the timely detection and treatment of HHcy and MetS are important for preventing CKD.

Suggested Citation

  • Hana Moon & Hae-Jin Ko & A-Sol Kim, 2020. "Hyperhomocysteinemia Concurrent with Metabolic Syndrome Is Independently Associated with Chronic Kidney Disease among Community-Dwelling Adults in an Urban Korean Population," IJERPH, MDPI, vol. 17(18), pages 1-15, September.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:18:p:6810-:d:415499
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/18/6810/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/18/6810/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Liying Zhang & Zhiyong Yuan & Wu Chen & Shanying Chen & Xinyu Liu & Yan Liang & Xiaofei Shao & Hequn Zou, 2014. "Serum Lipid Profiles, Lipid Ratios and Chronic Kidney Disease in a Chinese Population," IJERPH, MDPI, vol. 11(8), pages 1-14, July.
    2. Jing Zeng & Miao Liu & Lei Wu & Jianhua Wang & Shanshan Yang & Yiyan Wang & Yao Yao & Bin Jiang & Yao He, 2016. "The Association of Hypertriglyceridemic Waist Phenotype with Chronic Kidney Disease and Its Sex Difference: A Cross-Sectional Study in an Urban Chinese Elderly Population," IJERPH, MDPI, vol. 13(12), pages 1-10, December.
    3. Tadashi Toyama & Kengo Furuichi & Toshiharu Ninomiya & Miho Shimizu & Akinori Hara & Yasunori Iwata & Shuichi Kaneko & Takashi Wada, 2013. "The Impacts of Albuminuria and Low eGFR on the Risk of Cardiovascular Death, All-Cause Mortality, and Renal Events in Diabetic Patients: Meta-Analysis," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-12, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:18:p:6810-:d:415499. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.